The researchers of the University of Gothenburg in Sweden have developed a potential Diarrhea vaccine.
About:
Enterotoxigenic E. coli (ETEC) bacteria are a primary cause of diarrhea, leading to substantial illness and death in children in low- and middle-income countries (LMICs). Currently there is no ETEC vaccine available on the market for use in children in ETEC high-risk areas.
Now, an oral ETEC vaccine candidate, named ETVAX, was developed at University of Gothenburg in collaboration with Scandinavian Biopharma, Stockholm.
ETVAX consists of inactivated E. coli bacteria expressing high levels of protective antigens and the ETEC-based B subunit protein LCTBA.
Science journal, The Lancet, reports that it has been proved safe and effective in an early-stage clinical trial in Bangladesh against enterotoxigenic E. coli diarrhea in children from 6 months to 5 years of age.
Dear Student,
You have still not entered your mailing address. Please enter the address where all the study materials will be sent to you. (If applicable).
